Production (Stage)
Creative Medical Technology Holdings, Inc.
CELZ
$2.18
-$0.02-0.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 55.56% | 22.22% | -55.28% | -76.90% | -87.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.56% | 22.22% | -55.28% | -76.90% | -87.77% |
| Cost of Revenue | 55.56% | 22.22% | -45.68% | -68.66% | -83.41% |
| Gross Profit | 55.56% | 22.22% | -60.00% | -80.35% | -89.60% |
| SG&A Expenses | -0.13% | -9.01% | 6.00% | -1.75% | -3.45% |
| Depreciation & Amortization | 10.91% | 16.93% | 23.26% | 16.41% | 9.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.63% | 2.23% | -44.43% | -37.17% | -45.12% |
| Operating Income | -11.56% | -2.20% | 44.40% | 36.86% | 44.82% |
| Income Before Tax | -15.42% | -3.91% | 45.87% | 38.71% | 47.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.42% | -3.91% | 45.87% | 38.71% | 47.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.42% | -3.91% | 45.87% | 38.71% | 47.45% |
| EBIT | -11.56% | -2.20% | 44.40% | 36.86% | 44.82% |
| EBITDA | -11.57% | -1.95% | 45.02% | 37.38% | 45.31% |
| EPS Basic | -0.70% | 2.20% | 45.27% | 38.60% | 52.22% |
| Normalized Basic EPS | -0.70% | 2.20% | 45.27% | 38.60% | 52.22% |
| EPS Diluted | -0.70% | 2.20% | 45.27% | 38.60% | 52.22% |
| Normalized Diluted EPS | -0.70% | 2.20% | 45.27% | 38.60% | 52.22% |
| Average Basic Shares Outstanding | 14.83% | 5.17% | -1.05% | 0.07% | 10.10% |
| Average Diluted Shares Outstanding | 14.83% | 5.17% | -1.05% | 0.07% | 10.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |